Viewing Study NCT03326193

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-03-02 @ 8:03 PM
Study NCT ID: NCT03326193
Status: COMPLETED
Last Update Posted: 2025-07-31
First Post: 2017-10-10
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Sponsor: Tesaro, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitor View
None Ovarian Cancer View
None Primary Peritoneal carcinoma View
None Fallopian Tube View
None Vascular endothelial growth factor (VEGF) inhibitor View
None Bevacizumab View
None Niraparib View